Home > Research > Publications & Outputs > Using bisphosphonates to control the pain of bo...
View graph of relations

Using bisphosphonates to control the pain of bone metastases: evidence-based guidelines for palliative care.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Using bisphosphonates to control the pain of bone metastases: evidence-based guidelines for palliative care. / Mannix, Kathryn; Ahmedzai, Sam Hjelmeland; Anderson, Heather et al.
In: Palliative Medicine, Vol. 14, No. 6, 09.2000, p. 455-461.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Mannix, K, Ahmedzai, SH, Anderson, H, Bennett, MI, Lloyd-Williams, M & Wilcock, A 2000, 'Using bisphosphonates to control the pain of bone metastases: evidence-based guidelines for palliative care.', Palliative Medicine, vol. 14, no. 6, pp. 455-461. https://doi.org/10.1191/026921600701536372

APA

Mannix, K., Ahmedzai, S. H., Anderson, H., Bennett, M. I., Lloyd-Williams, M., & Wilcock, A. (2000). Using bisphosphonates to control the pain of bone metastases: evidence-based guidelines for palliative care. Palliative Medicine, 14(6), 455-461. https://doi.org/10.1191/026921600701536372

Vancouver

Mannix K, Ahmedzai SH, Anderson H, Bennett MI, Lloyd-Williams M, Wilcock A. Using bisphosphonates to control the pain of bone metastases: evidence-based guidelines for palliative care. Palliative Medicine. 2000 Sept;14(6):455-461. doi: 10.1191/026921600701536372

Author

Mannix, Kathryn ; Ahmedzai, Sam Hjelmeland ; Anderson, Heather et al. / Using bisphosphonates to control the pain of bone metastases: evidence-based guidelines for palliative care. In: Palliative Medicine. 2000 ; Vol. 14, No. 6. pp. 455-461.

Bibtex

@article{9282235e27e54024b23cb9aeb367dbaa,
title = "Using bisphosphonates to control the pain of bone metastases: evidence-based guidelines for palliative care.",
abstract = "This work was undertaken by the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland (APM) as a demonstration project in developing clinical guidelines relevant to palliative care from a pragmatic approach to literature review and grading of clinical evidence. CANCERLIT and Embase were searched for relevant papers written in English, published since 1980. Each study identified was rated against agreed criteria for levels of evidence. Most studies were not specifically designed to define speed of response, and were not undertaken in palliative care patients. Thus, careful reading and grading of each study was necessary. Sufficient evidence was identified to make recommendations for clinical practice in a palliative care population of patients, and areas for future research have been identified. Bisphosphonates appear to have a role in managing pain from metastases which has been refractory to conventional analgesic management and where oncological or orthopaedic intervention is delayed or inappropriate.",
keywords = "pain relief • bone metastases • bisphosphonates • clinical guidelines",
author = "Kathryn Mannix and Ahmedzai, {Sam Hjelmeland} and Heather Anderson and Bennett, {Michael I.} and Mari Lloyd-Williams and Andrew Wilcock",
year = "2000",
month = sep,
doi = "10.1191/026921600701536372",
language = "English",
volume = "14",
pages = "455--461",
journal = "Palliative Medicine",
issn = "1477-030X",
publisher = "SAGE Publications Ltd",
number = "6",

}

RIS

TY - JOUR

T1 - Using bisphosphonates to control the pain of bone metastases: evidence-based guidelines for palliative care.

AU - Mannix, Kathryn

AU - Ahmedzai, Sam Hjelmeland

AU - Anderson, Heather

AU - Bennett, Michael I.

AU - Lloyd-Williams, Mari

AU - Wilcock, Andrew

PY - 2000/9

Y1 - 2000/9

N2 - This work was undertaken by the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland (APM) as a demonstration project in developing clinical guidelines relevant to palliative care from a pragmatic approach to literature review and grading of clinical evidence. CANCERLIT and Embase were searched for relevant papers written in English, published since 1980. Each study identified was rated against agreed criteria for levels of evidence. Most studies were not specifically designed to define speed of response, and were not undertaken in palliative care patients. Thus, careful reading and grading of each study was necessary. Sufficient evidence was identified to make recommendations for clinical practice in a palliative care population of patients, and areas for future research have been identified. Bisphosphonates appear to have a role in managing pain from metastases which has been refractory to conventional analgesic management and where oncological or orthopaedic intervention is delayed or inappropriate.

AB - This work was undertaken by the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland (APM) as a demonstration project in developing clinical guidelines relevant to palliative care from a pragmatic approach to literature review and grading of clinical evidence. CANCERLIT and Embase were searched for relevant papers written in English, published since 1980. Each study identified was rated against agreed criteria for levels of evidence. Most studies were not specifically designed to define speed of response, and were not undertaken in palliative care patients. Thus, careful reading and grading of each study was necessary. Sufficient evidence was identified to make recommendations for clinical practice in a palliative care population of patients, and areas for future research have been identified. Bisphosphonates appear to have a role in managing pain from metastases which has been refractory to conventional analgesic management and where oncological or orthopaedic intervention is delayed or inappropriate.

KW - pain relief • bone metastases • bisphosphonates • clinical guidelines

U2 - 10.1191/026921600701536372

DO - 10.1191/026921600701536372

M3 - Journal article

VL - 14

SP - 455

EP - 461

JO - Palliative Medicine

JF - Palliative Medicine

SN - 1477-030X

IS - 6

ER -